Baxter Intl Inc Stock Price, News & Analysis

Amerant Bancorp (NYSE: AMTB) has announced the appointment of two new board members: Patricia "Patty" Morrison and Jack Kopnisky. Morrison brings extensive technology leadership experience as former CIO of Cardinal Health and board expertise from various Fortune 500 companies. Kopnisky contributes over 40 years of financial services experience, most recently serving as Executive Chairman of Webster Financial Corporation.

These appointments follow the addition of Lisa Lutoff-Perlo and Odilon Almeida Júnior to the board in January 2025, demonstrating Amerant's commitment to strategic growth and board strengthening as it aims to become Florida's bank of choice.

Baxter International (NYSE:BAX) has released its 2024 Corporate Responsibility Report, highlighting progress toward its 2030 sustainability goals. The company achieved a 13.5% reduction in greenhouse gas emissions compared to 2023 and invested $12 million in energy conservation projects.

Key accomplishments include investing $31.5 million in underserved communities, implementing circular economy initiatives, and maintaining top quartile workplace safety performance. The company completed 175 energy projects, including solar installations and a biomass-fired steam generator. Baxter's charitable giving reached over 100 countries, with $4 million specifically supporting communities affected by Hurricane Helene.

The report includes a double materiality assessment following the sale of its Kidney Care business in January 2025, along with SASB and TCFD indices for transparent reporting.

Baxter International (NYSE:BAX), a global medtech leader, announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference 2025. The company's Chief Financial Officer, Joel Grade, will deliver a presentation on Tuesday, June 10, 2025, at 10:40 a.m. Eastern Time. Investors and interested parties can access the live webcast of the presentation through Baxter's website (www.baxter.com). The presentation replay will remain available until December 7, 2025.

Baxter International (NYSE: BAX) has announced a quarterly cash dividend of $0.17 per share of common stock. The dividend will be paid on July 1, 2025, to stockholders of record as of May 30, 2025. Based on this quarterly distribution, the indicated annual dividend rate for Baxter shareholders stands at $0.68 per share of common stock.

Baxter International (NYSE:BAX) reported strong Q1 2025 results, with sales from continuing operations reaching $2.63 billion, up 5% on both reported and operational basis. The company posted U.S. GAAP EPS of $0.13 and adjusted EPS of $0.55, exceeding previous guidance. U.S. sales grew 11% to $1.49 billion, while international sales reached $1.14 billion. All three segments showed growth: Medical Products & Therapies ($1.26B, +3%), Healthcare Systems & Technologies ($704M, +6%), and Pharmaceuticals ($581M, +1%). Following these results, Baxter raised the bottom end of its full-year 2025 adjusted EPS guidance to $2.47-$2.55 and expects sales growth of 7-8% on a reported basis.

The company recently launched Voalte Linq device with voice-activation technology and introduced room-temperature storage Hemopatch Sealing Hemostat in Europe.

Baxter, a global medtech leader, has announced its participation in the upcoming Bank of America Securities 2025 Health Care Conference. The presentation is scheduled for Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time.

Joel Grade, Baxter's chief financial officer, will be representing the company at the conference. Interested parties can access the live webcast through www.baxter.com. The presentation recording will remain available for replay until Sunday, November 9, 2025.

Baxter International (NYSE:BAX), a global medtech leader, has announced it will host a conference call to discuss its first-quarter 2025 financial results. The call is scheduled for Thursday, May 1, 2025, at 7:30 a.m. Central Time. Investors can pre-register for the call through a provided registration link. The conference call will also be accessible via webcast through Baxter's website.

Baxter International Inc. (NYSE:BAX) has announced the launch of an enhanced version of Hemopatch Sealing Hemostat that can now be stored at room temperature in Europe. This evolution eliminates the need for refrigeration, making the product more accessible in operating rooms for immediate use during critical situations.

Hemopatch Sealing Hemostat is a ready-to-use absorbable collagen pad designed for tissue sealing, dura sealing, and hemostasis in both open and minimally invasive surgeries. The product consists of a soft, flexible collagen pad derived from bovine dermis, coated with NHS-PEG, and features blue squares on the non-coated side for differentiation.

According to real-world data across Europe, the product has demonstrated effectiveness in achieving rapid and sustainable hemostasis across various surgical specialties. This product enhancement is a result of collaboration between surgeons and Baxter, addressing the critical need for immediate access during surgical procedures.

Baxter International (NYSE:BAX) has announced its 2025 Annual Meeting of Stockholders will be held virtually on Tuesday, May 6, 2025 at 9 a.m. Central Time. The virtual format aims to provide accessible, safe, and cost-effective participation for all stockholders.

Stockholders of record can attend by accessing virtualshareholdermeeting.com/BAX2025 with their 16-digit control number. Questions can be submitted either before the meeting (April 22-May 5) through proxyvote.com or live during the event. Voting options include pre-meeting methods outlined in proxy materials or electronic voting during the meeting.

The meeting will also be accessible to guests in listen-only mode, though they won't have voting or question-asking privileges. Online access opens at 8:45 a.m. Central Time, and stockholders holding shares in 'street name' should follow their broker's instructions for attendance.